nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody theranostics in precision medicine
|
Wu, Qianyun |
|
|
|
2 |
p. 69-74 |
artikel |
2 |
A Prediction Model to Prioritize Individuals for a SARS-CoV-2 Test Built from National Symptom Surveys
|
Shoer, Saar |
|
|
|
2 |
p. 196-208.e4 |
artikel |
3 |
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
|
Hippich, Markus |
|
|
|
2 |
p. 149-163.e4 |
artikel |
4 |
A sensory-motor hand prosthesis with integrated thermal feedback
|
Muheim, Jonathan |
|
|
|
2 |
p. 118-125.e5 |
artikel |
5 |
A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma
|
Ask, Eivind Heggernes |
|
|
|
2 |
p. 180-195.e5 |
artikel |
6 |
Balancing macrophage polarization via stem cell-derived apoptotic bodies for diabetic wound healing
|
Mao, Jiayi |
|
|
|
2 |
p. 148-168.e8 |
artikel |
7 |
Breastfeeding enrichment of B. longum subsp. infantis mitigates the effect of antibiotics on the microbiota and childhood asthma risk
|
Dai, Darlene L.Y. |
|
|
|
2 |
p. 92-112.e5 |
artikel |
8 |
Can breastfeeding promote an antibiotic-resilient microbiome?
|
Stokholm, Jakob |
|
|
|
2 |
p. 67-68 |
artikel |
9 |
Cell-free plasma RNA signatures as a surrogate biomarker of pregnancy health
|
Afshar, Yalda |
|
|
|
2 |
p. 90-92 |
artikel |
10 |
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
|
Khoo, Nicholas Kim Huat |
|
|
|
2 |
p. 104-118.e4 |
artikel |
11 |
Elevated Blood Pressure Increases Pneumonia Risk: Epidemiological Association and Mendelian Randomization in the UK Biobank
|
Zekavat, Seyedeh M. |
|
|
|
2 |
p. 137-148.e4 |
artikel |
12 |
Enfortumab vedotin and pembrolizumab as new first-line standard for metastatic urothelial cancer
|
Zhu, Xiaolin |
|
|
|
2 |
p. 106-108 |
artikel |
13 |
Finding healing where it hurts
|
Gill, Jay |
|
|
|
2 |
p. 80-82 |
artikel |
14 |
Gemcitabine with cisplatin and nivolumab: Redefining standard of care for first-line metastatic urothelial carcinoma?
|
Mathew Thomas, Vinay |
|
|
|
2 |
p. 109-111 |
artikel |
15 |
Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease
|
Krishnaraj, Aishwarya |
|
|
|
2 |
p. 130-138.e1 |
artikel |
16 |
HBV reactivation and clinical resolution in an isolated anti-HBc-positive patient during immune checkpoint inhibition
|
Baumert, Lukas S. |
|
|
|
2 |
p. 126-131.e1 |
artikel |
17 |
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
|
Frost, Joe N. |
|
|
|
2 |
p. 164-179.e12 |
artikel |
18 |
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
|
Nuñez, Nicolas Gonzalo |
|
|
|
2 |
p. 113-129.e7 |
artikel |
19 |
Ironing Out Vaccine Efficacy
|
Peace, Christian G. |
|
|
|
2 |
p. 113-114 |
artikel |
20 |
Isoform-selective TGF-β3 inhibition for systemic sclerosis
|
Sun, Tianhe |
|
|
|
2 |
p. 132-147.e7 |
artikel |
21 |
Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth
|
Yang, Lifeng |
|
|
|
2 |
p. 119-136.e8 |
artikel |
22 |
Ketotherapy: Cutting carbs to treat cancer
|
Radyk, Megan D. |
|
|
|
2 |
p. 87-89 |
artikel |
23 |
LIBRETTO-431: Is it time to reconsider randomized phase 3 trials for uncommon oncogenic drivers in non-small-cell lung cancer?
|
Russo, Alessandro |
|
|
|
2 |
p. 112-114 |
artikel |
24 |
MARIPOSA-2: Is the treatment worse than the disease?
|
Lee, Alexandria T.M. |
|
|
|
2 |
p. 115-117 |
artikel |
25 |
Molecular Medicine: Found in Translation
|
Orkin, Stuart H. |
|
|
|
2 |
p. 122-136 |
artikel |
26 |
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
|
Mao, Long |
|
|
|
2 |
p. 169-171 |
artikel |
27 |
Race and kidney function: The facts and fix amidst the fuss, fuzziness, and fiction
|
Powe, Neil R. |
|
|
|
2 |
p. 93-97 |
artikel |
28 |
Race, ethnicity, and health: Old diseases, structural discrimination, and the next generation
|
Ramu, Swapnika |
|
|
|
2 |
p. 75-76 |
artikel |
29 |
Rare Disease Day: Amplifying voices, advocating hope
|
Cederroth, Helene |
|
|
|
2 |
p. 103-105 |
artikel |
30 |
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
|
Healy, Katie |
|
|
|
2 |
p. 137-153.e3 |
artikel |
31 |
Sickle cell disorder—it’s time to level up
|
Gbangbola, Kye |
|
|
|
2 |
p. 83-84 |
artikel |
32 |
Structural discrimination in emergency care: How a sick system affects us all
|
Hsia, Renee Y. |
|
|
|
2 |
p. 98-103 |
artikel |
33 |
The era of in vivo T cell engineering
|
Campos Ramos, Gustavo |
|
|
|
2 |
p. 85-86 |
artikel |
34 |
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer
|
Kiemen, Ashley L. |
|
|
|
2 |
p. 75-91 |
artikel |
35 |
To See, Study, and Serve
|
Demby, Suuba M. |
|
|
|
2 |
p. 77-79 |
artikel |
36 |
Virtual Undergraduate Research Experiences: More Than a Pandemic Stopgap
|
Samad, Tahoura |
|
|
|
2 |
p. 118-121 |
artikel |
37 |
Will Long-Acting Antiretroviral Therapy be a Game Changer Globally?
|
Ndung’u, Thumbi |
|
|
|
2 |
p. 115-117 |
artikel |